GALNT7 promotes the malignant progression of gastrointestinal stromal tumors by regulating KIT O-GalNAc glycosylation
Precision Clinical Medicine · 11.04.2026 · 9 (2)
DOI: 10.1093/pcmedi/pbag016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Clinical Medicine, online erschienen am 27.05.2026. Verfasst von Jiahao Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: First Affiliated Hospital of Zhengzhou University, National Natural Science Foundation of China, Zhengzhou University Basic Research Project for Young Students.
Abstract (Originalsprache)
Background
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract and is mainly driven by activating KIT or PDGFRA mutations. Although tyrosine kinase inhibitors (TKIs) improve outcomes, primary and acquired resistance remain major challenges, especially in high-risk and wild-type GIST. Protein O-linked N-acetylgalactosamine (O-GalNAc) glycosylation regulates protein stability and signaling, but its role in GIST remains unclear.
Methods
Bulk RNA-seq, proteomic, and single-cell RNA-seq data were integrated to identify O-glycosylation-related programs and key glycosyltransferases in GIST. Functional assays in GIST-T1 and GIST-882 cells, together with xenograft models, were performed to assess the effects of GalNAc-transferase 7 (GALNT7). GALNT7–KIT interaction, KIT O-GalNAcylation, and protein stability were examined by co-immunoprecipitation, VVA lectin blotting, confocal microscopy, and cycloheximide chase assays. Benzyl-α-GalNAc was evaluated as an O-glycosylation-targeting strategy in vitro and in vivo.
Results
O-glycosylation signatures were enriched in high-risk GIST and correlated with pathological risk. High O-glycosylation scores co-segregated with elevated copy-number variation in a fibroblast-like malignant cell population. GALNT7 was identified as a hub gene, upregulated in GIST, and associated with poor progression-free survival. GALNT7 promoted GIST cell growth, migration, and xenograft formation. Mechanistically, GALNT7 interacted with KIT, catalyzed its Tn-antigen O-GalNAcylation, increased KIT protein stability, and sustained PI3K/AKT and MAPK/ERK1/2 signaling. Benzyl-α-GalNAc reduced KIT O-GalNAcylation and stability, attenuated GALNT7-driven phenotypes, and inhibited xenograft growth.
Conclusions
GALNT7-mediated O-GalNAc glycosylation stabilizes KIT and drives GIST progression. GALNT7 may serve as a prognostic biomarker and therapeutic target in GIST.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Förderung
- First Affiliated Hospital of Zhengzhou University
- National Natural Science Foundation of China
- Zhengzhou University Basic Research Project for Young Students
- Natural Science Foundation of Henan Province
Zitieren
APA
Liu, J., Wu, S., Wang, Y., Zhang, G., Li, J., Wang, Z., Yin, Y., Liu, H., Peng, S., & Fu, Y. (2026). GALNT7 promotes the malignant progression of gastrointestinal stromal tumors by regulating KIT O-GalNAc glycosylation. Precision Clinical Medicine, 9(2). https://doi.org/10.1093/pcmedi/pbag016
Vancouver
Liu J, Wu S, Wang Y, Zhang G, Li J, Wang Z, et al. GALNT7 promotes the malignant progression of gastrointestinal stromal tumors by regulating KIT O-GalNAc glycosylation. Precision Clinical Medicine. 2026;9(2). doi:10.1093/pcmedi/pbag016
BibTeX
@article{Liu2026,
author = {Liu, Jiahao and Wu, Sihan and Wang, Yunfei and Zhang, Ge and Li, Jiehan and Wang, Zhen and Yin, Yuhan and Liu, Hao and Peng, Sanfei and Fu, Yang},
title = {GALNT7 promotes the malignant progression of gastrointestinal stromal tumors by regulating KIT O-GalNAc glycosylation},
journal = {Precision Clinical Medicine},
year = {2026},
volume = {9},
number = {2},
doi = {10.1093/pcmedi/pbag016}
}
EUVIMED